Brief: Park City says signed agreement with bio-pharmaceutical manufacturer to pilot repositrak's Track & Trace solution
Sept 22 (Reuters) - Park City Group Inc PCYG.O : * Says signed agreement with bio-pharmaceutical manufacturer to pilot repositrak's track & trace solution * Repositrak will provide manufacturer with visibility to product movement through supply chain and guard against entry of counterfeit drugs * Source text for Eikon ID:nBw9wkLVza * Further company coverage PCYG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Repositrak
See all newsRepositrak Q3 revenue flat, operating income rises 24%
Brief: ReposiTrak Inc - James R. Gillis To Rejoin Repositrak Board Effective March 13, 2026
Repositrak's Q2 revenue rises 7%, EPS up 13%
Brief: Repositrak Announces Second Patent-Pending Within Its Enterprise Platform For Touchless Traceability™ Technology
Brief: ReposiTrak and National Grocers Association Deepen Exclusive Partnership With Traceability, Compliance, and Scan-based Trading Endorsements